RSNA 2011 

Abstract Archives of the RSNA, 2011


LL-MKS-SU5B

US-guided Treatment of Patellar and Achilles Tendons with Autologous Platelet Gel

Scientific Informal (Poster) Presentations

Presented on November 27, 2011
Presented as part of LL-MKS-SU: Musculoskeletal Imaging

Participants

Antonio Barile, Presenter: Nothing to Disclose
Armando Conchiglia, Abstract Co-Author: Nothing to Disclose
Ada Riva, Abstract Co-Author: Nothing to Disclose
Cristino D'anniballe, Abstract Co-Author: Nothing to Disclose
Francesco Arrigoni, Abstract Co-Author: Nothing to Disclose
Luigi Zugaro, Abstract Co-Author: Nothing to Disclose
Carlo Masciocchi, Abstract Co-Author: Nothing to Disclose

PURPOSE

Evaluate the efficacy and safety of the treatment of tendinosis of Patellar and Achilles tendon with platelet gel. Today, tendinosis and not-acute injuries of the tendons are not treated surgically, but using drugs and physical therapy to reduce pain and, consequently, improve function. The platelet gel is employed in the therapy of tendonitis due to its anti-inflammatory effect that reduces pain and its regenerative action on the tissue, that allows improvement of function.

METHOD AND MATERIALS

We evaluated fifty-seven patients with lesions of patellar and Achilles tendon (23 patellar tendons and 34 Achilles tendons). The patients were evaluated from both the clinical and functional points of view by VAS (for pain), VISA-A and VISA-P (for function of Achilles and patellar tendons, respectively). The instrumental evaluation was carried out by means of US and MRI. Our protocol included three US-guided infiltrations at a distance of 21 days the one from the other, preceded by clinical, functional and US assessments. MRI control was performed both before treatment and 30 days after the last infiltration.

RESULTS

With regards to the Achilles tendon, the mean VAS at the end of treatment improved overall by 76% (from 7.2 to 1.7), and the VISA-A scale by 52% (from 79 to 37.8). With regards to the patellar tendon, the mean VAS improved by 71% (from 7.6 to 2.2) and the VISA-P by 51% (from 76.2 to 37.4). We observed morphological recovery and normalization of MRI signal in 90%. We observed a reduction of sectional area in the Achilles tendon in 30/34 cases (10-15%, 21 pts; 15-20%, 9 pts). Three patients presented an increased area by 10%. With regards to the patellar tendon we observed a reduction of the sectional area in 13 cases. In 10 patients no differences were observed.

CONCLUSION

Our study shows that the use of platelet gel not only gives satisfactory results in terms of symptoms and function in patients with tendinosis, but it also allows a considerable morphological recovery.

CLINICAL RELEVANCE/APPLICATION

The platelet gel is employed in the therapy of tendonitis due to its anti-inflammatory effect that reduces pain and its regenerative action on the tissue, that allows improvement of function.

Cite This Abstract

Barile, A, Conchiglia, A, Riva, A, D'anniballe, C, Arrigoni, F, Zugaro, L, Masciocchi, C, US-guided Treatment of Patellar and Achilles Tendons with Autologous Platelet Gel.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11034510.html